FDA Adverse Event Malfunction Summary report: N

ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2011132 · Received March 8, 2011

Report

Report Number
2122870-2011-00526
Event Type
Malfunction
Date Received
March 8, 2011
Date of Event
February 5, 2011
Report Date
February 8, 2011
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K922826
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PER CUSTOMER SUPPLIED DATA, RESULT FOR SAMPLE #1 WAS NOT CORRECTED IN THE LAB INFORMATION SYSTEM (LIS) AFTER REPEAT TESTING. THE SAMPLE WAS COLLECTED IN A LITHIUM HEPARIN TUBE THAT WAS CENTRIFUGED AT 3,500 RPM. THE SPECIMEN WAS NORMAL IN APPEARANCE. QC WAS RECOVERING WITHIN ESTABLISHED RANGES ON AND BEFORE THE DATE OF EVENT. SYSTEM CHECKS PERFORMED ON (B)(6) 2011 PASSED WITH SPECIFICATIONS. A FIELD SERVICE ENGINEER (FSE) PERFORMED A PREVENTIVE MAINTENANCE (PM). THE FSE PERFORMED A SYSTEM CHECK WHICH PASSED WITHIN SPECIFICATIONS. THE FSE RAN 30 REPS OF TROPONIN USING WASH BUFFER. ALL RESULTS WERE 0.00NG/ML. THE SYSTEM WAS RETURNED TO THE CUSTOMER FOR PATIENT TESTING. NO DEFINITIVE ROOT CAUSE WAS DETERMINED FOR THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC., (BCI) REGARDING AN ERRONEOUSLY ELEVATED TROPONIN (ACCU TNI) RESULT GENERATED BY THE ACCESS IMMUNOASSAY SYSTEM FOR ONE PATIENT. REPEAT TESTING ON A DIFFERENT METHOD RECOVERED LOWER RESULTS WITHIN THE NORMAL REFERENCE RANGE. TWO FRESH SAMPLES COLLECTED FROM THE PATIENT ON THE NEXT DAYS AND TESTED ON THE ACCESS ANALYZER ALSO GAVE RESULTS WITHIN THE NORMAL REFERENCE RANGE. THE RESULT WAS REPORTED OUT OF THE LAB. THE CUSTOMER DID NOT REPORT EFFECT TO THE PATIENT OR USER ATTRIBUTED OR CONNECTED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. ACCESS® IMMUNOASSAY SYSTEM

Patients

Seq Age Sex Outcome Treatment
1 45 YR